معرفی
Dr. Lucy Gibson is an NIHR Clinical Lecturer in Old Age Psychiatry (Dementia) at the Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience at King's College London. She joined King's in 2015 as an NIHR Academic Foundation Programme trainee in Neuropsychiatry and commenced clinical training in Core Psychiatry at South London and Maudsley NHS Foundation Trust in 2017 with an NIHR Academic Clinical Fellowship. Her research is conducted within the Research Centre for Healthy Brain Ageing, which focuses on biomarker development in neurocognitive disorders and novel strategies for early diagnosis of Alzheimer's disease and related disorders.
Dr. Gibson's research interests center on neuropsychiatry with a particular focus on immunopsychiatry and the intersection between autoimmune disorders and cognitive function. Her work examines the psychiatric manifestations and demographic differences in autoimmune encephalitis, with special attention to neuronal autoantibodies and their impact on cognition in both encephalitis and broader neurodegenerative contexts. She has developed significant expertise in neuropsychiatric symptoms across dementia spectrum disorders, particularly in dementia with Lewy bodies and Parkinson's disease.
Analysis of her publication record reveals a strong focus on biomarkers (particularly plasma phosphorylated tau and neurofilament light chain), neuropsychiatric symptoms in neurodegenerative disorders, and the relationship between autoimmune factors and cognitive decline. Her research spans clinical characterization, biomarker development, systematic reviews of therapeutic approaches, and exploration of pathophysiological mechanisms linking autoimmunity and neurodegeneration.
- NIHR Academic Foundation Programme trainee in Neuropsychiatry
- NIHR Academic Clinical Fellowship at King's College London
- Alzheimer's Society funded PhD under Professor Dag Aarsland
Dr. Gibson is actively involved in research at the Research Centre for Healthy Brain Ageing, collaborating with Professor Dag Aarsland and other leading researchers in the field of neurodegenerative disorders. Her work contributes to multiple UN Sustainable Development Goals, particularly those related to health and well-being. She has established collaborations across multiple institutions and countries, as evidenced by her extensive co-authorship network in high-impact journals.
